Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Also known as alprazolam oral tablet, alprazolam commercial immediate release oral tablet
Xanax · 1 trial · 1 indication
| Arm | Type | Description |
|---|---|---|
| Xanax XR tablets 3 mg (sourced from Caugus) | ACTIVE_COMPARATOR | Xanax XR tablets 3 mg (sourced from Caugus), 1 x 3 mg (REFERENCE) |
| Xanax XR tablets 3 mg (sourced from Barceloneta), | EXPERIMENTAL | Xanax XR tablets 3 mg (sourced from Barceloneta), 1 x 3 mg (TEST) |
| Name | Type | Description |
|---|---|---|
| Xanax XR tablets 3 mg (sourced from Caugus) | DRUG | Tablets, 3 mg, single dose |
| Xanax XR tablets 3 mg (sourced from Barceloneta) | DRUG | Tablets, 3 mg, single dose |
Inclusion Criteria: * Healthy male and/or female subjects between the ages of 20 and 55 years, inclusive. * An informed consent document signed and dated by the subject. Exclusion Criteria: * Evidence or history of clinically significant abnormality. * A positive urine drug screen. * Subjects who...
Xanax is used for the treatment of anxiety and panic disorders. It is a small molecule drug developed by Viatris Inc. (VTRS). The drug is currently in Phase 1 clinical development, with ongoing studies evaluating its safety and pharmacokinetics in healthy volunteers.
Xanax is developed by Viatris Inc., a global healthcare company traded on the NASDAQ under the ticker VTRS. The company is conducting Phase 1 clinical trials to evaluate the drug's safety and pharmacokinetics in healthy volunteers.
Xanax is in Phase 1 clinical development. It is an investigational drug, not yet approved by regulatory authorities. The Phase 1 trials are designed to assess the drug's safety, tolerability, and pharmacokinetic profile in healthy volunteers.
Xanax has completed three Phase 1 clinical trials, all conducted in the United States. These include NCT00647634, NCT00647894, and NCT00650299, which evaluated the fasting and fed pharmacokinetics of alprazolam extended-release tablets compared to Xanax XR tablets in healthy volunteers.
Xanax is a brand name for alprazolam. The clinical trials for Xanax are studies of alprazolam extended-release tablets, comparing them to the reference product Xanax XR. These studies are conducted in healthy volunteers to assess bioequivalence.